781
Views
6
CrossRef citations to date
0
Altmetric
Articles

Hemoglobin extravasation in the brain of rats exchange-transfused with hemoglobin-based oxygen carriers

, , , , , , ORCID Icon & show all
Pages 710-716 | Received 28 Oct 2016, Accepted 18 Nov 2016, Published online: 01 Dec 2016

References

  • Baldwin AL. 1999. Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery. Am J Physiol. 277:H650–H659.
  • Baldwin AL. 2004. Blood substitutes and redox responses in the microcirculation. Antioxid Redox Signal. 6:1019–1030.
  • Bucci E, Matheson B, Kwansa H, Koehler RC. 2006. Development of non-extravasating hemoglobin-based oxygen carriers. In: Winslow R, Ed. Blood Substitutes. London: Academic Press, pp. 488–497.
  • Butt OI, Buehler PW, D’Agnillo F. 2011. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am J Pathol. 178:1316–1328.
  • Cole R, Vandegriff K, Szeri A, Savas O, Winslow R. 2008. Targeted O2 delivery by blood substitutes: in vitro arteriolar simulations of first- and second-generation products. Microvasc Res. 76:169–179.
  • Hall CN, Attwell D. 2008. Assessing the physiological concentration and targets of nitric oxide in brain tissue. J Physiol (Lond.). 586:3597–3615.
  • Hartog CS, Kohl M, Reinhart K. 2011. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg. 112:635–645.
  • Keipert PE, Gomez CL, Gonzales A, MacDonald VW, Hess JR, Winslow RM. 1994. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med. 123:701–711.
  • Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM, et al. 2011. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res. 71:2260–2275.
  • Lancaster JR, Jr. 1994. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA. 91:8137–8141.
  • Leevers SJ, Marshall CJ. 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11:569–574.
  • Misra HP, Fridovich I. 1972. The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem. 247:6960–6962.
  • Mitsuishi Y, Motohashi H, Yamamoto M. 2012. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol. 2:200.
  • Mollan TL, Alayash AI. 2013. Redox reactions of hemoglobin: mechanisms of toxicity and control. Antioxid Redox Signal. 18:2251–2253.
  • Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I. 2004. Role of nitric oxide after brain ischaemia. Cell Calcium. 36:265–275.
  • Nagababu E, Ramasamy S, Rifkind JM, Jia Y, Alayash AI. 2002. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry. 41:7407–7415.
  • Olsen S, Malavalli A, Vandegriff K. 2012. Correlation between hemoglobin oxygen affinity and nitrite reductase activity. FASEB J. 26:573–574.
  • Powanda DD, Chang TM. 2002. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol. 30:23–37.
  • Ryter SW, Alam J, Choi AM. 2006. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 86:583–650.
  • Samaja M, Terraneo L. 2011. Impact of hemoglobin concentration and affinity for oxygen on tissue oxygenation: the case of hemoglobin-based oxygen carriers. Artif Organs. 36:210–223.
  • Schelshorn DW, Schneider A, Kuschinsky W, Weber D, Kruger C, Dittgen T, et al. 2009. Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab. 29:585–595.
  • Shah ZA, Li RC, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S, Dore S. 2007. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience. 147:53–59.
  • Shelton P, Jaiswal AK. 2013. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J. 27:414–423.
  • Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G, Jr. 1999. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 282:1857–1864.
  • Stein AB, Bolli R, Dawn B, Sanganalmath SK, Zhu Y, Wang OL, et al. 2012. Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol. 52:228–236.
  • Svergun DI, Ekström F, Vandegriff KD, Malavalli A, Baker DA, Nilsson C, Winslow RM. 2008. Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic. Biophys J. 94:173–181.
  • Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D. 2011. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr Opin Clin Nutr Metab Care. 14:41–48.
  • Tsai AG, Vandegriff KD, Intaglietta M, Winslow RM. 2003. Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol. 285:H1411–H1419.
  • Vandegriff KD, Bellelli A, Samaja M, Malavalli A, Brunori M, Winslow RM. 2004. Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin. Biochem J. 382:183–189.
  • Vandegriff KD, Malavalli A, Lohman J, Young MA, Terraneo L, Virgili E, et al. 2014. Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats. Transfusion. 54:2045–2054.
  • Vandegriff KD, Malavalli A, Minn C, Jiang E, Lohman J, Young MA, Samaja M, Winslow RM. 2006. Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J. 399:463–471.
  • Vandegriff KD, Malavalli A, Wooldridge J, Lohman J, Winslow RM. 2003. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 43:509–516.
  • Vandegriff KD, McCarthy M, Rohlfs RJ, Winslow RM. 1997. Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated. Biophys Chem. 69:23–30.
  • Young MA, Lohman J, Malavalli A, Vandegriff KD, Winslow RM. 2009. Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch. J Cardiothorac Vasc Anesth. 23:339–347.
  • Young MA, Riddez L, Kjellström BT, Bursell J, Winslow F, Lohman J, Winslow RM. 2005. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med. 33:1794–1804.
  • Young MA, Riddez L, Kjellström BT, Winslow RM. 2007. Effect of maleimide-polyethylene glycol hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: comparison with crystalloid and blood. J Trauma. 63:1234–1244.
  • Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC, Aronowski J. 2007. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke. 38:3280–3286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.